For his innovation in the production and application of medical isotopes; for advancing the separation and purification of actinides and heavy elements; and for his leadership in the use of alpha emitters to save the lives of cancer patients.
For his broad scientific contributions and international reputation in aqueous chemistry and geochemistry; for his research into the structure, dynamics, and reactions at fluid–solid interfaces; and for his leadership and service to ORNL and the international scientific community.
Since 2001, Mike Simpson has been a group leader for the Nanofabrication Research Laboratory and theme leader in the Center for Nanophase Materials Sciences. His research focus includes noise biology, nano-enabled synthetic biology and controlled synthesis and directed assembly of carbon nanostructures.
For pioneering research and distinguished contributions to the field of high-temperature superconductors, including fundamental materials science advances and technical innovations that enable commercialization.
For innovative research in nuclear structure physics, particularly in areas leading to a quantitative understanding of the excitation and decay of the elementary collective modes of nuclei, and for vision and scientific and technical leadership in building the Holifield Radioactive Ion Beam Facility into a forefront laboratory for nuclear science.
For pioneering research in disturbance and landscape ecology and in modeling of land-use change with its implications for global changes, which have influenced environmental decision making on a worldwide scale.
For forefront studies of the fundamental science of actinide elements, through mendelevium, which employ novel experimental techniques, make systematic comparisons, and emphasize the role of the elements' electronic configurations.